- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
3D MR brings new insight into bipolar disorders
Three-D MR is lending new muscle to the theory that lithium rebuilds or repairs gray matter in specific regions of the brain in patients with bipolar disorders.
Three-D MR is lending new muscle to the theory that lithium rebuilds or repairs gray matter in specific regions of the brain in patients with bipolar disorders.
Principal investigator Carrie Bearden, Ph.D., and colleagues at the University of California, Los Angeles enrolled 28 adult patients with bipolar disorder, most of whom were being treated with lithium, and 28 healthy subjects. The investigators used 3D structural brain mapping to analyze gray matter spots at multiple cortical locations. They found a statistically significant difference in gray matter density between bipolar patients and control subjects in the brain regions that control attention, motivation, and emotion. The technique will help develop new treatments that match lithium's effectiveness but without its toxic effects, Bearden said.
Investigators published results in the July issue of Biological Psychiatry.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
